Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
OCDX was delisted on the 26th of May, 2022.
162 hedge funds and large institutions have $5B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 65 increasing their positions, 44 reducing their positions, and 24 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
100% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 24
48% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 44
16% more capital invested
Capital invested by funds: $4.31B → $5B (+$692M)
16% more funds holding
Funds holding: 140 → 162 (+22)
18% less call options, than puts
Call options by funds: $1.73M | Put options by funds: $2.11M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VI
Versor Investments
New York
|
+$86.6M |
| 2 |
BlackRock
New York
|
+$32.4M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$28.3M |
| 4 |
JP Morgan Chase
New York
|
+$26.6M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$14.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$56M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$23.9M |
| 3 |
AC
Armistice Capital
New York
|
-$23.7M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$22.4M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$20.9M |
OCDX Hedge Fund Activity: Q4 2021 in Review
162 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q4 2021, worth a combined $5B — up 16% from $4.31B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new OCDX positions and 24 closed out — a net gain of 24 holders — while 65 added to existing stakes and 44 trimmed.
The largest buyer was Versor Investments, adding an estimated $86.6M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $56M sold.
- 162 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q4 2021, up from 140 in Q3 2021.
- Funds reported $5B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q4 2021, up 16% quarter-over-quarter.
- 48 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q4 2021 and 24 closed out, a net change of +24 holders.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q4 2021 was Versor Investments, an estimated $86.6M added.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q4 2021 was Alyeska Investment Group, an estimated $56M sold.
Based on aggregated 13F filings for Q4 2021.